Conduit Pharmaceuticals Inc (NASDAQ:CDT) price on Thursday, July 03, rose 4.29% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.92.
A look at the stock’s price movement, the close in the last trading session was $2.8, moving within a range at $2.6673 and $2.93. The beta value (5-Year monthly) was 1.995. Turning to its 52-week performance, $1350.00 and $2.21 were the 52-week high and 52-week low respectively. Overall, CDT moved -9.60% over the past month.
Conduit Pharmaceuticals Inc’s market cap currently stands at around $2.21 million, with investors looking forward to this quarter’s earnings report slated for in August.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CDT is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
CDT’s current price about 15.01% and -35.97% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.59, while 7-day volatility ratio is 11.52% and 9.35% in the 30-day chart. Further, Conduit Pharmaceuticals Inc (CDT) has a beta value of 1.94.
If we refocus on Conduit Pharmaceuticals Inc (NASDAQ:CDT), historical trading data shows that trading volumes averaged 0.52 over the past 10 days and 414.48K over the past 3 months. The company’s latest data on shares outstanding shows there are 0.76 million shares.
The 1.46% of Conduit Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 4.54% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.1 million on 2025-06-13, giving us a short ratio of 0.22. The data shows that as of 2025-06-13 short interest in Conduit Pharmaceuticals Inc (CDT) stood at 1283.9999999999998 of shares outstanding, with shares short rising to 51021.0 registered in 2025-05-15. Current price change has pushed the stock -99.80% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CDT stock continues to rise going into the next quarter.
